{"id":819858,"date":"2025-02-28T07:33:50","date_gmt":"2025-02-28T12:33:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/"},"modified":"2025-02-28T07:33:50","modified_gmt":"2025-02-28T12:33:50","slug":"bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/","title":{"rendered":"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">DURHAM, N.C., Feb.  28, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5Fn4G1uojJ_h83FTecizpOqJ2v4QhbqP0VqmPaxa01trGBJMYzRSij5ekTPU77MsYL0vwH_0Ib1QDtXsKKYH2SnGqDXe-zGUv0HKFPQWkGrbz0BOxgzfvaVQfcipCg8jMsDh3qbGsno4b6CqgNfgEriBlOfzFsDsyXVj_caopW8=\" rel=\"nofollow\" target=\"_blank\">Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d),<\/a> a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.<\/p>\n<p>To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.<\/p>\n<p>A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NU6cpgmLQ_bIpyxADcbmRbFUVoPEWcnkoEArHcNaU3xoRdvpS2B1WMKr1_02ixoiB4w9gpxhxrpodchx2AAJjHPtXClzTTxTSs6EIrhF89g=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.bioventus.com\/<\/a>. The webcast will be archived at the same site and available for replay until March 10, 2026.<\/p>\n<p>\n        <strong>About Bioventus<\/strong><br \/>\n        <br \/>Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m6K8922BuVgAhitH_ozQIhkLBT92URmrnvryao_VCqQe6VFF_lI4-51elShMOR2UGGyZMRHat_CS2kBLTANOz76n_l6Xfex-FhHhr8ZdHtU=\" rel=\"nofollow\" target=\"_blank\">www.bioventus.com<\/a> and follow the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5KYJSXzojEjabyjfnxBUm7BKVAaRkIffFTru3qOF-IFFJ33b2VbxyZeVbJzt2tN-OW2WF3Me9wUid8sH60Zh9Ls6Kb5EDwvUkVavJW365m0=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6viZE7ASHdSNP3uuN7CugM3b5ZqtN5c-rTYfYYIqPtT2Hx6ja4a0NDSs5R8S5B-B_EMfrkdMEnhBGVTu2ZwBn3JZ5uPkHGM1Ilc_p9N-0hQ=\" rel=\"nofollow\" target=\"_blank\">Twitter<\/a>. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.<\/p>\n<p>\n        <strong>Investor and Media Inquiries:<\/strong><br \/>\n        <br \/>Dave Crawford<br \/>919-474-6787<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8eVPsn_yRBjp_TU1MAKNwDe5wFXUjEkgiGL98Bbvt8OKqmRN5Lg2YEpokV2o-j2dFpiu6oGq4CZ8IhhaXNDunQ9XlPZbM5zv9WJvh1np9YkcZdCdodhNc0kQuDofQADM\" rel=\"nofollow\" target=\"_blank\">Dave.Crawford@bioventus.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjUyYjA2MjQtZGViOS00MzE3LTliZDQtNmFhMTkyNTBhN2FmLTEwNDA2ODY=\/tiny\/Bioventus-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) &#8212; Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company&#8217;s website at https:\/\/ir.bioventus.com\/. The webcast will be archived at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-819858","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) &#8212; Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company&#8217;s website at https:\/\/ir.bioventus.com\/. The webcast will be archived at &hellip; Continue reading &quot;Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-28T12:33:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025\",\"datePublished\":\"2025-02-28T12:33:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/\",\"name\":\"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=\",\"datePublished\":\"2025-02-28T12:33:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/","og_locale":"en_US","og_type":"article","og_title":"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - Market Newsdesk","og_description":"DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) &#8212; Bioventus Inc. (Nasdaq: BVS) (\u201cBioventus\u201d or the \u201cCompany\u201d), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company\u2019s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the \u201cInvestor Relations\u201d section of the Company&#8217;s website at https:\/\/ir.bioventus.com\/. The webcast will be archived at &hellip; Continue reading \"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-28T12:33:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025","datePublished":"2025-02-28T12:33:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/","name":"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=","datePublished":"2025-02-28T12:33:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4NjMzMiM2NzgzMzU3IzIwMjkxMTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioventus-to-report-fourth-quarter-of-fiscal-year-2024-financial-results-on-march-11-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=819858"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819858\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=819858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=819858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=819858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}